Nirmish Shah, MD
Internal Medicine · Durham, NCNPI 1033113899
Payments from drug & device makers
Across 734 payments — averaging $2488.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Global Blood Therapeutics, Inc.$1M
- Novartis$328K
- Pfizer$258K
- AstraZeneca$108K
- Agios Pharmaceuticals, Inc.$39K
- Chiesi USA, Inc.$15K
- plus $54K from 11 others
Across 77 payments — averaging $1882.19 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Agios Pharmaceuticals, Inc.$95K
- Novartis$37K
- Pfizer$11K
- Sanofi US Services Inc.$1K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Global Blood Therapeutics, Inc. | 249 | $1,024,023 |
| Novartis | 128 | $328,222 |
| Pfizer | 176 | $258,447 |
| AstraZeneca | 95 | $107,900 |
| Agios Pharmaceuticals, Inc. | 30 | $38,711 |
| Chiesi USA, Inc. | 12 | $15,325 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $13,143 |
| Novo Nordisk | 9 | $12,392 |
| Emmaus Medical, Inc. | 15 | $10,203 |
| Genetix Biotherapeutics Inc | 3 | $5,850 |
| Vertex | 4 | $5,378 |
| Apo-pharma Inc. | 1 | $2,740 |
| GSK | 1 | $2,000 |
| Tersera Therapeutics LLC | 1 | $862 |
| Janssen Research & Development, LLC | 1 | $715 |
| Bayer | 1 | $671 |
| Biotissue Holdings Inc. | 1 | $111 |
How this compares
$1,826,694 in reported general payments places this provider in the 95th percentile of 3,302 internal medicine providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other internal medicine in Durham
- Manesh PatelDurham$27.2M
- Adam DevoreDurham$11.8M
- Krishnakumar UdayakumarDurham$11M
- April SalamaDurham$6.5M
- Hope UronisDurham$5M
- Richard RiedelDurham$2.6M
- Jamie ToddDurham$1.9M
- Aparna SwaminathanDurham$1.2M
- Cynthia MoylanDurham$907K
- Mehri McKellarDurham$824K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.